George David S, Ainslie-Garcia Margaret H, Ferko Nicole C, Cheng Hang
The Eye MDs, Parkersburg, WV, USA.
Physicians Outpatient Surgery Center, Belpre, OH, USA.
Clin Ophthalmol. 2021 Mar 2;15:923-929. doi: 10.2147/OPTH.S293111. eCollection 2021.
To calculate the minimum number of Femtosecond laser-assisted cataract surgery (FLACS) procedures required per month to pay off the fixed investment cost over 5 years to achieve break-even.
A rural ophthalmology practice located in the mid-West United States.
An economic analysis, based on real-world, retrospectively collected data over 12 months, from an ambulatory surgical care perspective.
FLACS was initiated in 2017 with the LenSx laser (Alcon Vision LLC., Fort Worth, TX). The incremental cost of FLACS, cases needed to break-even, return on investment (ROI), patient education, and marketing efforts were assessed. The financial analysis considered cataract volume, conversion rates, fixed (eg, principal) and variable (eg, supplies) costs, and revenue in the first 12 months.
The clinic performed 2717 cataract surgeries in the 12-month period, with 1304 (48%) of patients converting to FLACS. Of FLACS procedures, 613 (47%) selected an advanced-technology intraocular lens (AT-IOL; eg, toric or lifestyle IOL), and the remaining patients selected a monofocal IOL with laser astigmatism correction. FLACS increased AT-IOL use by 113 procedures (23%) compared to volumes in the year prior to FLACS. Overall, FLACS was predicted to be profitable, with only 13 cases required per month to break even in 5 years. If both facility and physician fees are considered revenue, only eight cases per month are required to break-even in 5 years.
The practice experienced a greater-than-anticipated conversion to FLACS and increased selection of AT-IOLs, well above the break-even volume required, contributing to a rapid return on their investment.
计算每月所需的飞秒激光辅助白内障手术（FLACS）最少例数，以便在5年内收回固定投资成本从而实现收支平衡。
位于美国中西部的一家乡村眼科诊所。
基于12个月内回顾性收集的实际数据，从门诊手术护理角度进行的经济分析。
2017年开始使用LenSx激光（爱尔康视觉有限责任公司，得克萨斯州沃思堡）开展FLACS。评估了FLACS的增量成本、实现收支平衡所需的病例数、投资回报率（ROI）、患者教育及营销努力。财务分析考虑了白内障手术量、转化率、固定成本（如本金）和可变成本（如耗材）以及前12个月的收入。
该诊所在12个月期间共进行了2717例白内障手术，其中1304例（48%）患者转为接受FLACS。在接受FLACS手术的患者中，613例（47%）选择了先进技术人工晶状体（AT-IOL；如散光或功能性人工晶状体），其余患者选择了带激光散光矫正的单焦点人工晶状体。与FLACS开展前一年的手术量相比，FLACS使AT-IOL的使用增加了113例（23%）。总体而言，预计FLACS将实现盈利，5年内每月仅需13例手术即可实现收支平衡。如果将机构费用和医生费用都视为收入，那么5年内每月仅需8例手术就能实现收支平衡。
该诊所向FLACS的转变比预期更为显著，并且对AT-IOL的选择增加，远高于所需的收支平衡量，这有助于其投资的快速回报。
